PT Bundamedik Tbk (ISX:BMHS) COGS-to-Revenue : 0.53 (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is PT Bundamedik Tbk COGS-to-Revenue?

PT Bundamedik Tbk's Cost of Goods Sold for the three months ended in Mar. 2024 was Rp219,167 Mil. Its Revenue for the three months ended in Mar. 2024 was Rp413,751 Mil.

PT Bundamedik Tbk's COGS to Revenue for the three months ended in Mar. 2024 was 0.53.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. PT Bundamedik Tbk's Gross Margin % for the three months ended in Mar. 2024 was 47.03%.

PT Bundamedik Tbk COGS-to-Revenue Historical Data

The historical data trend for PT Bundamedik Tbk's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Bundamedik Tbk COGS-to-Revenue Chart

PT Bundamedik Tbk Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

0.53

0.57

0.48

0.54

0.53

PT Bundamedik Tbk Quarterly Data
	Dec18	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
COGS-to-Revenue	Get a 7-Day Free Trial												0.53	0.54	0.53	0.53	0.53

PT Bundamedik Tbk COGS-to-Revenue Calculation

PT Bundamedik Tbk's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	792384.606	/	1488197.483
	=	0.53

PT Bundamedik Tbk's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	219167.444	/	413751.175
	=	0.53

PT Bundamedik Tbk (ISX:BMHS) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

PT Bundamedik Tbk's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	219167.444 / 413751.175
	=	47.03 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

PT Bundamedik Tbk COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of PT Bundamedik Tbk's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

PT Bundamedik Tbk (ISX:BMHS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » PT Bundamedik Tbk (ISX:BMHS) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

Jl. Teuku Cik Ditiro No.28, Menteng, Jakarta Pusat, IDN, 10350

Website

https://www.bmhs.co.id

PT Bundamedik Tbk is a healthcare service provider. It offers maternal and child health services, outpatient services, inpatient services, emergency services, service excellence centers, IVF services, and Clinical laboratory services.

PT Bundamedik Tbk (ISX:BMHS) Headlines

No Headlines